BRIEF-AstraZeneca Says Transfer Of Rights To Eklira, Duaklir Completed


Reuters | Updated: 05-01-2022 12:45 IST | Created: 05-01-2022 12:43 IST
BRIEF-AstraZeneca Says Transfer Of Rights To Eklira, Duaklir Completed
Representative Image Image Credit: Twitter (@AstraZeneca)

AstraZeneca PLC:

* ASTRAZENECA PLC - TRANSFER OF RIGHTS TO EKLIRA, DUAKLIR COMPLETED

* ASTRAZENECA - TRANSFER OF GLOBAL RIGHTS FOR EKLIRA AND DUAKLIR TO COVIS PHARMA COMPLETED Source text for Eikon: Further company coverage:

Also Read: BRIEF-AstraZeneca Plc Says Ultomiris Accepted For FDA Priority Review For gMG

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback